Adalimumab effect on pain in hidradenitis suppurativa patients: systematic review and meta-analysis
Introduction: Pain is experienced by most patients with hidradenitis suppurativa (HS) and has a severe impact on their quality of life. Its management still presents a challenge. Adalimumab, a TNF-a antagonist, has shown promising results in HS-related pain reduction. Objectives: To aggregate and sy...
Saved in:
Main Authors: | Aikaterini Tsentemeidou (Author), Elena Sotiriou (Author), Nikolaos Sideris (Author), Alexandra Kourouklidou (Author), Aimilios Lallas (Author), Dimitrios Ioannides (Author), Efstratios Vakirlis (Author) |
---|---|
Format: | Book |
Published: |
Mattioli1885,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Work Impairment in Hidradenitis Suppurativa Compared to Psoriasis: A Cross-Sectional Study
by: Aikaterini Tsentemeidou, et al.
Published: (2024) -
Apremilast survival and reasons for discontinuation in psoriasis: five-year experience from a Greek tertiary care centre
by: Elena Sotiriou, et al.
Published: (2022) -
Apremilast in psoriasis patients with serious comorbidities: a case series and systematic review of literature
by: Aikaterini Tsentemeidou, et al.
Published: (2022) -
Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa
by: Fotiadou C, et al.
Published: (2016) -
Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data
by: Aikaterini Kyriakou, et al.
Published: (2018)